0000899243-18-005333.txt : 20180223
0000899243-18-005333.hdr.sgml : 20180223
20180223170042
ACCESSION NUMBER: 0000899243-18-005333
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180222
FILED AS OF DATE: 20180223
DATE AS OF CHANGE: 20180223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hatfield Jeffrey S.
CENTRAL INDEX KEY: 0001609879
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36510
FILM NUMBER: 18637472
MAIL ADDRESS:
STREET 1: 11080 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZAFGEN, INC.
CENTRAL INDEX KEY: 0001374690
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 203857670
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 175 PORTLAND STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02114
BUSINESS PHONE: 617-622-4003
MAIL ADDRESS:
STREET 1: 175 PORTLAND STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02114
FORMER COMPANY:
FORMER CONFORMED NAME: ZAFGEN INC
DATE OF NAME CHANGE: 20060906
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-02-22
0
0001374690
ZAFGEN, INC.
ZFGN
0001609879
Hatfield Jeffrey S.
C/O ZAFGEN, INC.
175 PORTLAND STREET, 4TH FLOOR
BOSTON
MA
02114
1
1
0
0
Chief Executive Officer
Stock Option (Right to Buy)
7.77
2018-02-22
4
A
0
275000
0.00
A
2028-02-22
Common Stock
275000
275000
D
25% of this option vests on February 22, 2019, and the remainder vests in equal monthly installments thereafter over 36 months.
/s/ Laurie Burlingame, Attorney-in-Fact
2018-02-23